TY - JOUR
T1 - The human multidrug resistance 1 promoter has an element that responds to serum starvation
AU - Tanimura, Hideyuki
AU - Kohno, Kimitoshi
AU - Sato, Shin ichi
AU - Uchiumi, Takeshi
AU - Miyazaki, Miki
AU - Kobayashi, Michio
AU - Kuwano, Michihiko
N1 - Funding Information:
We thank Dr. M. Ono for useful discussion, and we also thank M. Kamino and T. Umeda of our laboratory for preparing this manuscript. This study was supported by grant - in - aid for cancer research grant from the Ministry of Education, Science and Culture Japan, and the Ministry of Health and Welfare, Japan, a research grant of the Princess Takamatsu Cancer Research Fund, and Japanese Foundation for Multidisciplinary Treatment of Cancer.
PY - 1992/3/16
Y1 - 1992/3/16
N2 - We have previously demonstrated in transient expression assay systems that a human multidrug resistance 1 (MDR1) promoter can be directly activated by cytotoxic anticancer agents. In this study, we examined whether the MDR1 promoter could be regulated in response to growth arrest induced by serum starvation. We have established human and rodent cell lines which stably expressed the chloramphenicol acetyltransferase (CAT) gene driven by various lengths of the MDR1, the viral thymidine kinase (TK) and the simian virus 40 (SV40) promoters. Serum starvation caused enhanced expression of CAT gene with MDR1 promoter, but not with two viral gene promoters in human cancer KB cells. Hydroxyurea activated the MDR1 promoter, but not TK and SV40 promoters. By contrast, the DNA topoisomerase II inhibitor, etoposide, equally activated the MDR1, TK and SV 40 promoters. Increased CAT gene expression by serum starvation was also specifically observed in stable transfertants of human adrenal SW-13 cell lines, but not in stable transfectants of mouse fibroblast NIH3T3 and adrenal Y-1 cell lines when the human MDR1 promoter-CAT was introduced. Etoposide, however, effectively induced CAT activity in both human and rodent cells. Assays with deletion constructs of the MDR1 promoter showed that serum starvation activated the MDR1 promoter carrying -258 ∼ +121 base sequence of the promoter, but not -198 ∼ +121 of the promoter. These results suggest that the expression of the MDR1 gene induced by serum starvation is regulated at the transcriptional level in a promoter sequence-specific manner in human cells.
AB - We have previously demonstrated in transient expression assay systems that a human multidrug resistance 1 (MDR1) promoter can be directly activated by cytotoxic anticancer agents. In this study, we examined whether the MDR1 promoter could be regulated in response to growth arrest induced by serum starvation. We have established human and rodent cell lines which stably expressed the chloramphenicol acetyltransferase (CAT) gene driven by various lengths of the MDR1, the viral thymidine kinase (TK) and the simian virus 40 (SV40) promoters. Serum starvation caused enhanced expression of CAT gene with MDR1 promoter, but not with two viral gene promoters in human cancer KB cells. Hydroxyurea activated the MDR1 promoter, but not TK and SV40 promoters. By contrast, the DNA topoisomerase II inhibitor, etoposide, equally activated the MDR1, TK and SV 40 promoters. Increased CAT gene expression by serum starvation was also specifically observed in stable transfertants of human adrenal SW-13 cell lines, but not in stable transfectants of mouse fibroblast NIH3T3 and adrenal Y-1 cell lines when the human MDR1 promoter-CAT was introduced. Etoposide, however, effectively induced CAT activity in both human and rodent cells. Assays with deletion constructs of the MDR1 promoter showed that serum starvation activated the MDR1 promoter carrying -258 ∼ +121 base sequence of the promoter, but not -198 ∼ +121 of the promoter. These results suggest that the expression of the MDR1 gene induced by serum starvation is regulated at the transcriptional level in a promoter sequence-specific manner in human cells.
UR - http://www.scopus.com/inward/record.url?scp=0026562709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026562709&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(92)90571-2
DO - 10.1016/0006-291X(92)90571-2
M3 - Article
C2 - 1550597
AN - SCOPUS:0026562709
SN - 0006-291X
VL - 183
SP - 917
EP - 924
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -